Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684435 · ClinicalTrials.gov registry record · Phase 2
Contrast-enhanced Ultrasound of the Kidney
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT02684435: Completed Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
NCT02684435 is a Phase 2 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 63 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02684435, a Phase 2 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate contrast-enhanced ultrasound for kidney malignancies
Primary Outcome
Lesions will be assessed for change in size, calcification, and septation based on Bosniak criteria (I, II, IIF, III, IV) to determine whether a lesion has progressed, regressed, or is stable.
Interventions
- DRUG Perflutren lipid microsphere
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-07-09 |
| Phase | Phase 2 |
What the finished NCT02684435 record still lists
NCT02684435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Perflutren lipid microsphere is the first listed.
NCT02684435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02684435 about?
NCT02684435 is a clinical study titled "Contrast-enhanced Ultrasound of the Kidney". The purpose of this research study is to evaluate contrast-enhanced ultrasound for kidney malignancies
What is the current status of trial NCT02684435?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2016-02. Estimated completion is 2018-07-09.
What interventions are being tested in trial NCT02684435?
The interventions under investigation include: Perflutren lipid microsphere (DRUG).
Who is sponsoring clinical trial NCT02684435?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02684435's enrollment target sits among peer trials
63 1009th of 2000 higher than 985 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia